Aller au contenu
Santé mentale et cognitionRevue des preuves3 min read

Walking eases depression and anxiety symptoms versus no activity, not versus other exercise

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:The Effect of Walking on Depressive and Anxiety Symptoms: Systematic Review and Meta-Analysis. · JMIR public health and surveillance · 2024 · Article original ↗

À retenir

Across 75 randomized trials with 8636 participants, walking reduced depressive symptoms (SMD -0.591) and anxiety symptoms (SMD -0.446) in adults compared with inactive controls. Heterogeneity was high (I2 = 84.8% and 81.1%), and walking did no better than other active treatments.

Study design

Revue des preuves

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Walking is the most accessible form of exercise, but the mental health benefits of its different forms had not been brought together. The authors set out to measure how well various forms of walking reduce depression and anxiety symptoms, and whether the effect depends on frequency, duration, setting or format.

Population et méthode

Systematic review and random-effects meta-analysis of randomized controlled trials (RCTs) of walking on depressive and anxiety symptoms. MEDLINE, CENTRAL, Embase, PsycINFO, AMED, CINAHL and Web of Science were searched on April 5, 2022. Two authors independently screened studies and extracted data, results were pooled as standardized mean differences (SMDs) with 95% CIs, and risk of bias was assessed with the Cochrane Risk of Bias tool.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    75 RCTs with 8636 participants were included (68 reported depressive symptoms, 39 anxiety, 32 both). One adolescent study was left out of the meta-analysis.
  2. 2
    Compared with inactive controls, walking lowered depressive symptoms in adults (44 RCTs; SMD -0.591, 95% CI -0.778 to -0.403; I2 = 84.8%; P < .001) and anxiety symptoms (26 RCTs; SMD -0.446, 95% CI -0.628 to -0.265; I2 = 81.1%; P < .001).
  3. 3
    Walking helped in most subgroups, including different frequencies, durations, indoor or outdoor settings and group or individual formats (all P < .05). Adults with depression benefited more (5 RCTs; SMD -1.863, 95% CI -2.764 to -0.962) than those without (39 RCTs; SMD -0.442, 95% CI -0.604 to -0.280; P = .002 for the difference).
  4. 4
    Against active controls there was no significant difference for depressive symptoms (17 RCTs; SMD -0.126, 95% CI -0.343 to 0.092; P = .26) or anxiety symptoms (14 RCTs; SMD -0.053, 95% CI -0.311 to 0.206; P = .69).

Limites et incertitude

  1. 1
    Heterogeneity between trials was high (I2 from 58% to 86.4%), so the pooled effect hides large differences between studies.
  2. 2
    Only 5 trials covered adults with depression, so the larger benefit seen in that group rests on a small evidence base.
  3. 3
    The authors note that more evidence is needed on low-intensity walking.
  4. 4
    The abstract does not give the overall risk-of-bias findings, and this reading is based on the abstract only.

Mise en perspective

Walking is a reasonable, low-barrier option that appears to help low mood and anxiety symptoms compared with doing nothing, and about as much as other active approaches. It is not a substitute for treatment, so anyone with depression or anxiety should work with their clinician on a plan.

Vos données

Daily steps, walking minutes and walking location are easy to record with a phone or wearable, and you can log mood alongside them with a simple weekly rating. Compare your own weeks on the same device and look at the trend rather than single days.

Comprendre ce type de preuve

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Previous literature lacks summative information on the mental health benefits achieved from different forms of walking.

Objective

The aim of this study was to assess the effectiveness of different forms of walking in reducing symptoms of depression and anxiety.

Methods

This was a systematic review and meta-analysis of randomized controlled trials (RCTs) assessing the effects of walking on depressive and anxiety symptoms. MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL), Embase, PsycINFO, Allied and Complementary Medicine Database (AMED), CINAHL, and Web of Science were searched on April 5, 2022. Two authors independently screened the studies and extracted the data. Random-effects meta-analysis was used to synthesize the data. Results were summarized as standardized mean differences (SMDs) with 95% CIs in forest plots. The risk of bias was assessed by using the Cochrane Risk of Bias tool.

Results

This review included 75 RCTs with 8636 participants; 68 studies reported depressive symptoms, 39 reported anxiety symptoms, and 32 reported both as the outcomes. One study reported the results for adolescents and was not included in the meta-analysis. The pooled results for adults indicated that walking could significantly reduce depressive symptoms (RCTs: n=44; SMD -0.591, 95% CI -0.778 to -0.403; I2=84.8%; τ2=0.3008; P<.001) and anxiety symptoms (RCTs: n=26; SMD -0.446, 95% CI -0.628 to -0.265; I2=81.1%; τ2=0.1530; P<.001) when compared with the inactive controls. Walking could significantly reduce depressive or anxiety symptoms in most subgroups, including different walking frequency, duration, location (indoor or outdoor), and format (group or individual) subgroups (all P values were <.05). Adult participants who were depressed (RCTs: n=5; SMD -1.863, 95% CI -2.764 to -0.962; I2=86.4%; τ2=0.8929) and those who were not depressed (RCTs: n=39; SMD -0.442, 95% CI -0.604 to -0.280; I2=77.5%; τ2=0.1742) could benefit from walking effects on their depressive symptoms, and participants who were depressed could benefit more (P=.002). In addition, there was no significant difference between walking and active controls in reducing depressive symptoms (RCTs: n=17; SMD -0.126, 95% CI -0.343 to 0.092; I2=58%; τ2=0.1058; P=.26) and anxiety symptoms (14 RCTs, SMD -0.053, 95% CI -0.311 to 0.206, I2=67.7%, τ2=0.1421; P=.69).

Conclusions

Various forms of walking can be effective in reducing symptoms of depression and anxiety, and the effects of walking are comparable to active controls. Walking can be adopted as an evidence-based intervention for reducing depression and anxiety. More evidence on the effect of low-intensity walking is needed in the future.

Sources et attribution

The Effect of Walking on Depressive and Anxiety Symptoms: Systematic Review and Meta-Analysis.

Xu Z, Zheng X, Ding H, Zhang D, Cheung PM, Yang Z, Tam KW, Zhou W, Chan DC, Wang W, Wong SY.

JMIR public health and surveillance · 2024-07-23

DOI: 10.2196/48355 ↗PubMed · 39045858 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Synthèse de revues

Exercise gave small-to-moderate cognitive gains across 133 reviews of trials

An umbrella review of 133 systematic reviews (2724 trials, 258,279 participants) found that exercise improved general cognition (SMD 0.42, 95% CI 0.37 to 0.47), memory (0.26) and executive function (0.24), with the largest memory gains in children and adolescents and the largest executive function gains in people with ADHD. Most of the reviews (94) were rated critically low in quality and the effects were smaller in the best-rated ones (0.23 for general cognition), and the outcomes were test scores, not dementia.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse observationnelle

More daily steps linked to fewer depressive symptoms across 33 studies of adults

Pooling 33 observational studies of 96,173 adults, higher daily step counts went with fewer depressive symptoms, and in the two prospective cohorts that could be pooled, 7000 or more steps a day went with a lower risk of depression than fewer (RR 0.69, 95% CI 0.62-0.77). Most studies were cross-sectional, so low mood may be reducing steps as much as steps affect mood, and the authors say the prediction intervals call for caution.

JAMA Network Open

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Exercise eased depression in 218 trials, but confidence in the evidence is low

In a network meta-analysis of 218 trials with 14,170 people who met criteria for major depression, walking or jogging, yoga, strength training, mixed aerobic exercise and tai chi or qigong each gave moderate reductions in depression compared with active controls (walking or jogging: Hedges' g −0.62, 95% credible interval −0.80 to −0.45). Confidence in the evidence was low for walking or jogging and very low for the other treatments, mainly because only one study met the low-risk-of-bias criteria.

BMJ

Explications approfondiesLire l’étude →
·Synthèse de revues

Physical activity eased depression and anxiety across 97 reviews of trials

Across 97 systematic reviews that pooled 1039 randomized trials with 128,119 participants, physical activity had medium effects on depression (median effect size −0.43) and anxiety (−0.42) compared with usual care, and higher-intensity activity went with larger gains. Most of those reviews (77) were rated critically low in quality, and the evidence mainly concerns mild-to-moderate symptoms.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
Santé mentale et cognition →